Informations:
Erreur:
ID
13642
Description
Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion; ODM derived from: https://clinicaltrials.gov/show/NCT01349491
Lien
https://clinicaltrials.gov/show/NCT01349491
Mots-clés
Versions (1)
- 22/02/2016 22/02/2016 -
Téléchargé le
22 février 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Atrial Fibrillation NCT01349491
Eligibility Atrial Fibrillation NCT01349491
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT01349491
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
atrial fibrillation; age
Item
male or female with persistent atrial fibrillation, aged 21 or older
boolean
C0004238 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
atrial fibrillation
Item
duration of atrial fibrillation less than one year
boolean
C0004238 (UMLS CUI [1])
Anticoagulation contraindicated
Item
the patient does not have any contraindications for anticoagulation
boolean
C1531588 (UMLS CUI [1])
compliance
Item
the patient is willing to participate in the study for a total of 6 months with 3 outpatient office visits
boolean
C1321605 (UMLS CUI [1])
informed consent
Item
the patient has provided written informed consent during the screening visit to any test or procedure being performed, or medication being changed, for this study.
boolean
C0021430 (UMLS CUI [1])
laboratory value; patient safety
Item
the patient has no clinically significant abnormal clinical laboratory values, which in the investigator's opinion precludes the patient from safely participating in the study.
boolean
C0011911 (UMLS CUI [1])
C1113679 (UMLS CUI [2])
C1113679 (UMLS CUI [2])
Anticoagulation contraindicated
Item
any contraindication for anticoagulation
boolean
C1531588 (UMLS CUI [1])
new york heart association class iv
Item
new york heart association class iv heart failure
boolean
C1319796 (UMLS CUI [1])
anti-arrhythmic drugs
Item
currently taking anti-arrhythmic drugs
boolean
C0003195 (UMLS CUI [1])
chronic kidney disease; Liver Dysfunction
Item
chronic kidney disease (serum creatinine less than 2.5mg/dl) or severe liver dysfunction
boolean
C1561643 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
C0086565 (UMLS CUI [2])
pregnant; lactating
Item
pregnancy/nursing
boolean
C2828358 (UMLS CUI [1])
C0549206 (UMLS CUI [2])
C0549206 (UMLS CUI [2])
prolonged qt interval
Item
prolonged qt interval (>500ms)
boolean
C0151878 (UMLS CUI [1])
medication prolonged qt interval
Item
taking other medications known to prolong the qt interval
boolean
C0013227 (UMLS CUI [1,1])
C0151878 (UMLS CUI [1,2])
C0151878 (UMLS CUI [1,2])
ranolazine
Item
taking other medications known to affect the metabolism of ranolazine
boolean
C0073633 (UMLS CUI [1])